Home / GLP-1

GLP-1

Which Once-Weekly Type 2 Drug is Superior: Semaglutide or Exenatide? – Medical Newspaper

Researchers carried out a research to check as soon as-weekly semaglutide 1.zero mg with exenatide prolonged launch (ER) 2.zero mg in sufferers with sort 2 diabetes to see about their security and effectiveness. Semaglutide as soon as-weekly is within the GLP-1 receptor agonist class of diabetes medicine marketed as Ozempic …

Read More »

Making Sense of the Glycemic Index – Medical Newspaper

making sense of the glycemic index medical newspaper 310x165 - Making Sense of the Glycemic Index - Medical Newspaper

Mid-October, I went to the DiabetesSisters Weekend for Women convention Alexandria, Virginia. (See my disclaimer at the finish.) One of the excellent displays I attended was Thriveabetes 2016 speaker Gary Scheiner’s presentation on “Making use of the Glycemic Index.” This shouldn’t be a shock to anybody who has learn Gary’s e-book “Think Like …

Read More »

Diabetes Tech on the Horizon – New Insulin Delivery Systems Coming in 2018 – Medical Newspaper

diabetes tech on the horizon new insulin delivery systems coming in 2018 medical newspaper 310x165 - Diabetes Tech on the Horizon – New Insulin Delivery Systems Coming in 2018 - Medical Newspaper

This article is reprinted with permission from diaTribe. Find the authentic article right here. By Maeve Serino and Adam Brown  Learn about what’s new and what’s coming quickly in Smart Pens, automated insulin supply, pumps, and extra Diabetes know-how strikes quick, so that will help you maintain monitor, we’ve rounded …

Read More »

The Latest in Diabetes Drugs: Less Hypoglycemia, More Weight Loss – Medical Newspaper

the latest in diabetes drugs less hypoglycemia more weight loss medical newspaper 310x165 - The Latest in Diabetes Drugs: Less Hypoglycemia, More Weight Loss - Medical Newspaper

This article is reprinted with permission from diaTribe. Find the unique article right here. By Emma Ryan and Payal Marathe Research introduced at EASD 2017 showcased medicine, each new and outdated, that enhance blood sugar administration, weight reduction, coronary heart well being, and even blood stress New analysis introduced on …

Read More »

FDA Approves New Once-Weekly Ozempic for Type 2 Diabetes – Medical Newspaper

fda approves new once weekly ozempic for type 2 diabetes medical newspaper 310x165 - FDA Approves New Once-Weekly Ozempic for Type 2 Diabetes - Medical Newspaper

The FDA has permitted Novo Nordisk’s new kind 2 diabetes drug–the as soon as-weekly semaglutide, marketed as Ozempic. Ozempic, which is a part of a diabetes class of medication referred to as GLP-1 (glucagon peptide receptor agonist), lowers blood sugar by boosting insulin secretion. The FDA permitted semaglutide for adults …

Read More »

FDA Approves AstraZeneca’s Once-Weekly Bydureon BCise for Type 2 Diabetes

fda approves astrazenecas once weekly bydureon bcise for type 2 diabetes 310x165 - FDA Approves AstraZeneca’s Once-Weekly Bydureon BCise for Type 2 Diabetes

The FDA has authorized of AstraZeneca’s Bydureon BCise (exenetide extended-release) injectable drug for sort 2 diabetes. Bydureon BCise is a brand new method of Bydureon–this one is a once-weekly, single-dose auto injector tool supposed for adults with sort 2 diabetes whose blood sugar ranges are nonetheless now not neatly controlled …

Read More »

New Type 2 Diabetes Drug Gets Vote of Confidence from FDA Advisory Committee

new type 2 diabetes drug gets vote of confidence from fda advisory committee 310x165 - New Type 2 Diabetes Drug Gets Vote of Confidence from FDA Advisory Committee

Novo Nordisk has won a favorable 16-Zero vote from the FDA Advisory Committee for the approval of their kind 2 diabetes drug, semaglutide. Semaglutide is meant as a once-weekly kind 2 diabetes remedy and is an “investigational analog of local human glucagon-like peptide-1 (GLP-1) and, thru its top albumin binding …

Read More »